plerixafor has been researched along with cycloheximide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Darwin, ED; Li, J; Shao, H; Webster, KA; Wu, Q; Yang, B; Yu, H | 1 |
2 other study(ies) available for plerixafor and cycloheximide
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Extracellular calcium increases CXCR4 expression on bone marrow-derived cells and enhances pro-angiogenesis therapy.
Topics: Animals; Benzylamines; Bone Marrow Cells; Calcium; Chemotaxis; Cyclams; Cycloheximide; Dose-Response Relationship, Drug; Gene Expression Regulation; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Mice; Mice, Inbred C57BL; Neovascularization, Physiologic; Receptors, Calcium-Sensing; Receptors, CXCR4; Stem Cells | 2009 |